Literature DB >> 8390717

Cytomegalovirus associated inflammatory heart muscle disease.

B Maisch1, U Schönian, M Crombach, I Wendl, C Bethge, M Herzum, H H Klein.   

Abstract

Cytomegaloviruses(CMV) belong to a group of cardiotropic DNA-viruses with well-documented but sporadic cardiac involvement. By in situ hybridization with a biotinylated cDNA probe CMV-DNA was analysed in 2 different series of patients(1982-1988; 1989-1991) in the endomyocardial biopsy specimens of 35 patients with active myocarditis as defined by the Dallas criteria, and of 35 patients with acute perimyocarditis (pericardial effusion and cardiomegaly or segmental wall motion abnormality and/or an endomyocardial biopsy positive for active myocarditis) were analysed. 51% of patients with active myocarditis, 65% positive findings were observed in patients with perimyocarditis when all positive signals in the myocardium were taken into account. Since in interstitial cells and the vascular endothelium HCMV-DNA was also detected in controls we conclude that only HCMV-DNA in the nuclei are specific for HCMV-associated myocarditis. The incidence of positive signals in the myocytes was lower: 14% of all myocarditis patients and 8.5% of all pericarditis patients demonstrated this pattern. The results from in situ hybridization were compared to circulating anti-CMV antibodies from by an ELISA. As possible predisposing immunologic factors or associated alterations of effector functions we found a shift from normal to reduced natural killer cell activity and a marginal increase in B- and activated T-cells in the peripheral blood.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8390717

Source DB:  PubMed          Journal:  Scand J Infect Dis Suppl        ISSN: 0300-8878


  19 in total

1.  Fatal myocardial necrosis caused by Staphylococcus lugdunensis and cytomegalovirus in a patient with scleroderma.

Authors:  Laura Pirilä; Karl-Ove Söderström; Marja Hietarinta; Jari Jalava; Ville Kytö; Auli Toivanen
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

Review 2.  [Coronary heart disease as inflammatory disease of the vascular bed? Etiology, sequela or misconception?].

Authors:  B Maisch
Journal:  Herz       Date:  1998-05       Impact factor: 1.443

3.  Ganciclovir and cidofovir treatment of cytomegalovirus-induced myocarditis in mice.

Authors:  J C Lenzo; G R Shellam; C M Lawson
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

Review 4.  [Cardiotropic DNA viruses and bacteria in the pathogenesis of dilated cardiomyopathy with or without inflammation].

Authors:  S Pankuweit; G Hufnagel; H Eckhardt; H Herrmann; S Uttecht; B Maisch
Journal:  Med Klin (Munich)       Date:  1998-04-15

Review 5.  [Therapy of dilated cardiomyopathies with and without inflammation].

Authors:  G Hufnagel; S Pankuweit; B Maisch
Journal:  Med Klin (Munich)       Date:  1998-04-15

6.  [Classification of cardiomyopathies according to the WHO/ISFC Task Force--more questions than answers?].

Authors:  B Maisch
Journal:  Med Klin (Munich)       Date:  1998-04-15

7.  Activation of the NF-kappaB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter.

Authors:  Ian B DeMeritt; Liesl E Milford; Andrew D Yurochko
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 8.  Viral myocarditis: from experimental models to molecular diagnosis in patients.

Authors:  Sabine Pankuweit; Karin Klingel
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

9.  Type I interferon gene therapy protects against cytomegalovirus-induced myocarditis.

Authors:  Vanessa S Cull; Emmalene J Bartlett; Cassandra M James
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397

10.  Tricky brucellosis.

Authors:  Mojtaba Hedayat Yaghoobi; Bahaoddin Siroos; Morteza Foroumandi; Mehrnaz Asadi Gharabaghi
Journal:  BMJ Case Rep       Date:  2013-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.